Literature DB >> 34002352

Identification of prognostic factors and construction of a nomogram for patients with relapse/refractory adult-onset Still's disease.

Ruxue Yin1, Gangjian Wang2, Xiaopei Yang1, Lei Zhang1, Shuolin Wang1, Tianfang Li1, Shengyun Liu3.   

Abstract

OBJECTIVES: This study aimed to identify the risk factors for relapse/refractory adult-onset Still's disease (AOSD) and to construct and validate a prognostic nomogram for predicting the individual risk of relapse/refractory disease.
METHOD: A total of 174 patients were included in our study. Univariate and multivariate logistic regression analyses were used to identify relapse/refractory-associated factors, which were used to construct nomograms. Receiver operating characteristic (ROC) curve analysis, calibration curves, and decision curve analysis (DCA) were used to assess the predictive ability of the nomograms.
RESULTS: Univariate and multivariate logistic analyses showed that age, fever, disease duration, platelet count, serum ferritin level, and erythrocyte sedimentation rate were independent unfavourable factors for relapse/refractory AOSD (p < 0.05). We constructed a 6-factor nomogram based on univariate and multivariate logistic analyses. ROC analysis indicated that the area under the curve of the 6-factor nomogram in the training set and test set was 0.765 and 0.714, respectively. In addition, the calibration curves showed excellent prediction accuracy, and DCA showed superior net benefit in the 6-factor nomograms. Moreover, we evaluated the predictive effectiveness of our nomogram in females and young adults. The results showed that our 6-factor nomogram has the same predictive ability in both subgroups.
CONCLUSIONS: Novel nomograms based on clinical characteristics were developed and may be applied to help predict the individual risk of poor prognosis of patients. Key Points • Logistic regression was used to identify risk factors for relapse/refractory adult-onset Still's disease. • We then constructed a nomogram for predicting disease risk. • ROC analysis, calibration curves, and DCA all showed that the nomogram exerted good prediction ability in both the training set and test set. • The nomogram has the same predictive ability in both female and young adult subgroups.

Entities:  

Keywords:  Adult-onset Still’s disease; Nomogram; Refractory; Relapse

Year:  2021        PMID: 34002352     DOI: 10.1007/s10067-021-05722-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  26 in total

1.  Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases.

Authors:  B Fautrel; J Sibilia; X Mariette; B Combe
Journal:  Ann Rheum Dis       Date:  2004-06-07       Impact factor: 19.103

2.  Clinical features and prognosis in adult-onset Still's disease: a study of 104 cases.

Authors:  Xiao-Dan Kong; Dong Xu; Wen Zhang; Yan Zhao; Xiaofeng Zeng; Fengchun Zhang
Journal:  Clin Rheumatol       Date:  2010-06-14       Impact factor: 2.980

Review 3.  How I treat patients with adult onset Still's disease in clinical practice.

Authors:  Marcello Govoni; Alessandra Bortoluzzi; Daniela Rossi; Vittorio Modena
Journal:  Autoimmun Rev       Date:  2017-08-01       Impact factor: 9.754

4.  Adult-onset Still's disease-associated interstitial lung disease represents severe phenotype of the disease with higher rate of haemophagocytic syndrome and relapse.

Authors:  Yukiko Takakuwa; Hironari Hanaoka; Tomofumi Kiyokawa; Harunobu Iida; Kana Ishimori; Toshimasa Uekusa; Hidehiro Yamada; Kimito Kawahata
Journal:  Clin Exp Rheumatol       Date:  2019-02-11       Impact factor: 4.473

5.  The effect of tocilizumab on preventing relapses in adult-onset Still's disease: A retrospective, single-center study.

Authors:  Naoshi Nishina; Yuko Kaneko; Hideto Kameda; Tsutomu Takeuchi
Journal:  Mod Rheumatol       Date:  2014-11-17       Impact factor: 3.023

Review 6.  Pathogenesis of adult-onset Still's disease: new insights from the juvenile counterpart.

Authors:  Yvan Jamilloux; Mathieu Gerfaud-Valentin; Fabio Martinon; Alexandre Belot; Thomas Henry; Pascal Sève
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

7.  Misuse of DeLong test to compare AUCs for nested models.

Authors:  Olga V Demler; Michael J Pencina; Ralph B D'Agostino
Journal:  Stat Med       Date:  2012-03-13       Impact factor: 2.373

8.  Adult-onset Still's disease. Clinical course and outcome.

Authors:  J J Cush; T A Medsger; W C Christy; D C Herbert; L A Cooperstein
Journal:  Arthritis Rheum       Date:  1987-02

9.  Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers.

Authors:  Piero Ruscitti; Paola Cipriani; Francesco Masedu; Daniela Iacono; Francesco Ciccia; Vasiliki Liakouli; Giuliana Guggino; Francesco Carubbi; Onorina Berardicurti; Paola Di Benedetto; Marco Valenti; Giovanni Triolo; Gabriele Valentini; Roberto Giacomelli
Journal:  BMC Med       Date:  2016-12-01       Impact factor: 8.775

Review 10.  Pathogenesis, disease course, and prognosis of adult-onset Still's disease: an update and review.

Authors:  Meng-Yan Wang; Jin-Chao Jia; Cheng-De Yang; Qiong-Yi Hu
Journal:  Chin Med J (Engl)       Date:  2019-12-05       Impact factor: 2.628

View more
  2 in total

1.  Associated factors with poor treatment response to initial glucocorticoid therapy in patients with adult-onset Still's disease.

Authors:  Fumiaki Kondo; Takahiko Sugihara; Natsuka Umezawa; Hisanori Hasegawa; Tadashi Hosoya; Naoki Kimura; Masaaki Mori; Shinsuke Yasuda
Journal:  Arthritis Res Ther       Date:  2022-04-29       Impact factor: 5.606

Review 2.  Adult-Onset Still's Disease: Novel Biomarkers of Specific Subsets, Disease Activity, and Relapsing Forms.

Authors:  Beatrice Maranini; Giovanni Ciancio; Marcello Govoni
Journal:  Int J Mol Sci       Date:  2021-12-11       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.